Genomic Analysis Of The Novel Epigenetic Modifier Smchd1 As A Tumour Suppressor
Funder
National Health and Medical Research Council
Funding Amount
$619,142.00
Summary
Epigenetic modifications are changes made to our DNA that act like punctuation marks in the genome, to instruct the cell when to turn genes on and when to switch them off. Epigenetic control is critical to range of different biological processes, and also goes awry in cancer. We are specifically interested in the role of one new protein involved in epigentic control and characterising its role as a tumour suppressor.
Functional Characterization Of The Regulatory Architecture Of Melanoma-associated Loci
Funder
National Health and Medical Research Council
Funding Amount
$645,663.00
Summary
Melanoma accounts for more than 75% of skin cancer related deaths. In Australia, >10,000 new cases are diagnosed yearly. In this proposal, we will apply novel genetic sequencing technologies developed in our laboratory to examine genomic regions that are associated with melanoma development. By focusing on selected areas, we will obtain a much deeper understanding of how these genes are regulated and find new ways of detecting and treating this disease.
Targeting Homeobox Genes In Acute Myeloid Leukaemia
Funder
National Health and Medical Research Council
Funding Amount
$658,739.00
Summary
Acute myeloid leukaemia (AML) is a common blood cancer with dire clinical prognosis due to a lack of targeted molecular therapies. In this proposal we will identify new ways of targeting transcription factor proteins that are overexpressed in AML and promote leukaemia by repressing normal cellular growth controls. This may lead to novel methods to target leukaemic stem cells to specifically eliminate myeloid leukemia
Genomic Analysis Of The Role Of Polycomb Repressive Complex 2 (PRC2) In Haematopoietic Stem Cells
Funder
National Health and Medical Research Council
Funding Amount
$448,150.00
Summary
Epigenetic modifications are changes made to our DNA that act like punctuation marks in the genome, to instruct the cell when to turn genes on and when to switch them off. Epigenetic control is critical to range of different biological processes. We are specifically interested in how different components of the molecular epigenetic machinery interact and contribute to blood stem cell function.
Gene Expression Signature Technology To Repurpose Drugs For Bipolar Disorder
Funder
National Health and Medical Research Council
Funding Amount
$482,800.00
Summary
In this project we will generate a Gene Expression Signature that best characterises the overall biological effects of a cocktail of drugs currently used to treat bipolar disorder. The Signature will be identified in cells and intact brains, and then validated using human gene expression profiling. The validated Signature will then be used to screen libraries and discover new drugs for treating bipolar disorder.
Unlocking The Secrets Of Royal Jelly: From Recent Breakthroughs To Novel Drugs Targeting Anaplastic Lymphoma Kinase
Funder
National Health and Medical Research Council
Funding Amount
$348,763.00
Summary
Nature is a source of incommensurable chemical diversity that throughout history have provided many useful bioactive compounds including anti-cancer drugs. Our recent results suggest that honeybees use royal jelly to regulate the expression of genes implicated in certain types of human cancer.The aim of this study is to identify inhibitors of cancer related genes in royal jelly and to understand the mechanism of their action. Our results could lead to novel combination therapies.
CAGE: Consortium For The Architecture Of Gene Expression
Funder
National Health and Medical Research Council
Funding Amount
$501,080.00
Summary
This research project is about understanding why some people are most susceptible to disease than others, by identifying genetic factors that influence the expression of genes that are important in disease. We will work with leaders in the field in Europe and the USA in an international research consortium to find genetic variants with an effect on gene expression and to link those genetic factors to disease. The project will provide new understanding about the biological basis of common disease ....This research project is about understanding why some people are most susceptible to disease than others, by identifying genetic factors that influence the expression of genes that are important in disease. We will work with leaders in the field in Europe and the USA in an international research consortium to find genetic variants with an effect on gene expression and to link those genetic factors to disease. The project will provide new understanding about the biological basis of common diseases.Read moreRead less
Successful HIV remission and cure, where patients can live normally without daily drug therapy and risk of transmitting infectious virus, will critically depend on understanding the mechanisms that control the expression of viral messenger RNA and proteins. This project further explores the mechanisms controling poorly understood steps in the proecssing of viral mRNA that are required for HIV protein produciton, and identifies new targets and strategies to drive HIV into permanent remission.
Treatment Of Genetic Liver Disease By Homologous Recombination In Vivo, Coupled With A Pharmoco-genetic Strategy For Selective Expansion Of Genetically Repaired Hepatocytes
Funder
National Health and Medical Research Council
Funding Amount
$920,836.00
Summary
This project seeks to exploit recent advancements in our ability to precisely “edit” and correct mutations underlying human genetic diseases. To improve therapeutic efficiencies of the system, we will deliver the technology using highly efficient virus-based systems and apply a novel post-repair selection process to preferentially repopulate the liver with gene-repaired cells. Demonstration of the strategy in a humanised mouse model will provide important preclinical data for human applications.
Role Of IS26 In Antibiotic Resistance Gene Recruitment, Dissemination And Expression
Funder
National Health and Medical Research Council
Funding Amount
$457,879.00
Summary
Antibiotic resistance is increasing, compromising the efficacy of front-line antibiotics. Untreatable infections due to bacteria that are resistant to all available antibiotics are being seen more often. To control the spread of resistance, an understanding of how resistance arises and is spread among bacteria is needed. This requires information about how the genetic elements that mobilize them work. This project will study one of the most important of these elements.